Literature DB >> 9278442

Human lysyl-tRNA synthetase accepts nucleotide 73 variants and rescues Escherichia coli double-defective mutant.

K Shiba1, T Stello, H Motegi, T Noda, K Musier-Forsyth, P Schimmel.   

Abstract

The nucleotide 73 (N73) "discriminator" base in the acceptor stem is a key element for efficient and specific aminoacylation of tRNAs and of microhelix substrates derived from tRNA acceptor stems. This nucleotide was possibly one of the first to be used for differentiating among groups of early RNA substrates by tRNA synthetases. In contrast to many other synthetases, we report here that the class II human lysyl-tRNA synthetase is relatively insensitive to the nature of N73. We cloned, sequenced, and expressed the enzyme, which is a close homologue of the class II yeast aspartyl-tRNA synthetase whose co-crystal structure (with tRNAAsp) is known. The latter enzyme has a strong requirement for G73, which interacts with 4 of the 14 residues within the "motif 2" loop of the enzyme. Even though eukaryotic lysine tRNAs also encode G73, the motif 2 loop sequence of lysyl-tRNA synthetase differs at multiple positions from that of the aspartate enzyme. Indeed, the recombinant human lysine enzyme shows little preference for G, and even charges human tRNA transcripts encoding the A73 found in E. coli lysine tRNAs. Moreover, while the lysine enzyme is the only one in E. coli to be encoded by two separate genes, a double mutant that disables both genes is complemented by a cDNA expressing the human protein. Thus, the sequence of the loop of motif 2 of human lysyl-tRNA synthetase specifies a structural variation that accommodates nucleotide degeneracy at position 73. This sequence might be used as a starting point for obtaining highly specific interactions with any given N73 by simple amino acid replacements.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9278442     DOI: 10.1074/jbc.272.36.22809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Genetic dissection of protein-protein interactions in multi-tRNA synthetase complex.

Authors:  S B Rho; M J Kim; J S Lee; W Seol; H Motegi; S Kim; K Shiba
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

2.  Complementation of human immunodeficiency virus type 1 replication by intracellular selection of Escherichia coli formula supplied in trans.

Authors:  Anna McCulley; Casey D Morrow
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

3.  Nucleotides within the anticodon stem are important for optimal use of tRNA(Lys,3) as the primer for HIV-1 reverse transcription.

Authors:  Anna McCulley; Casey D Morrow
Journal:  Virology       Date:  2007-03-21       Impact factor: 3.616

4.  Substrate recognition by class I lysyl-tRNA synthetases: a molecular basis for gene displacement.

Authors:  M Ibba; H C Losey; Y Kawarabayasi; H Kikuchi; S Bunjun; D Söll
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

5.  Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding.

Authors:  Christopher P Jones; Siddhartha A K Datta; Alan Rein; Ioulia Rouzina; Karin Musier-Forsyth
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

6.  Viral hijacking of mitochondrial lysyl-tRNA synthetase.

Authors:  Monika Kaminska; Vyacheslav Shalak; Mathilde Francin; Marc Mirande
Journal:  J Virol       Date:  2006-10-18       Impact factor: 5.103

7.  Anticodon recognition and discrimination by the alpha-helix cage domain of class I lysyl-tRNA synthetase.

Authors:  Jeffrey D Levengood; Hervé Roy; Ryuichiro Ishitani; Dieter Söll; Osamu Nureki; Michael Ibba
Journal:  Biochemistry       Date:  2007-08-31       Impact factor: 3.162

8.  Species-specific differences in the operational RNA code for aminoacylation of tRNA(Trp).

Authors:  F Xu; X Chen; L Xin; L Chen; Y Jin; D Wang
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

9.  Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants.

Authors:  Marie Sissler; Mark Helm; Magali Frugier; Richard Giege; Catherine Florentz
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

10.  Ability of wild-type and mutant lysyl-tRNA synthetase to facilitate tRNA(Lys) incorporation into human immunodeficiency virus type 1.

Authors:  Shan Cen; Hassan Javanbakht; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.